Furthermore, in the context of hyperglycemia, hepatic expression and activation of FoxO6 significantly contribute to increased ApoC3 production, impairing plasma TG metabolism associated with aging in HFD-fed conditions. Here, FOXO6 is linked to Hyperglycemia.